Theravance Biopharma Inc. | Key People and Executives
Rick E. Winningham
Chairman & Chief Executive Officer
Eran Broshy
Independent Director
Laurie Smaldone Alsup
Independent Director
Donal M. O'Connor
Independent Director
Susan M. Molineaux
Independent Director
Dean Jonathan Mitchell
Independent Director
William D. Young
Lead Independent Director
George M. Whitesides
Independent Director
Peter S. Ringrose
Independent Director
Burton Gordon Malkiel
Independent Director
Robert V. Gunderson
Independent Director
Rick E. Winningham
Chairman & Chief Executive Officer
Renee D. Gala
Chief Financial Officer, Treasurer & SVP
Sharath S. Hegde
Senior Vice President-Research
Brett K. Haumann
Chief Medical Officer & SVP-Clinical Development
Shehnaaz Suliman
Senior VP-Corporate Development & Strategy
Frank C. Pasqualone
Chief Commercial Operations Officer & Senior VP
Philip Worboys
Senior Vice President-Translational Science
Junning Lee
Senior Vice President-Technical Operations
Alexander Dobbin
Head-Investor Relations
Dennis O. Driver
Chief Human Resources Officer & Vice President
Bradford J. Shafer
Secretary & Executive VP-General Counsel
Eran Broshy
Independent Director
Laurie Smaldone Alsup
Independent Director
Donal M. O'Connor
Independent Director
Susan M. Molineaux
Independent Director
Dean Jonathan Mitchell
Independent Director
William D. Young
Lead Independent Director
George M. Whitesides
Independent Director
Peter S. Ringrose
Independent Director
Burton Gordon Malkiel
Independent Director
Robert V. Gunderson
Independent Director
Address |
Ugland House George Town GT KY1 Cayman Islands
|
Employees
|
- |
Website |
http://www.theravance.com |
Updated |
07/08/2019 |
Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands. |